Children’s Hospital GME Support Reauthorization Act of 2025
Summary
HB2107, the Children’s Hospital GME Support Reauthorization Act of 2025, would extend and fund a federal program that makes payments to children’s hospitals that operate graduate medical education programs. The bill reauthorizes the program through fiscal year 2030 and updates the payment amounts for fiscal years 2026 through 2030, increasing the authorized funding levels for both the direct payment and related support streams.
In addition to the reauthorization, the bill adds a new restriction that would bar a children’s hospital from receiving these payments if, during the prior fiscal year, it furnished certain specified procedures or drugs to an individual under 18. The bill defines those procedures and drugs broadly to include gender-affirming surgeries and medications, while also creating exceptions for treatment of precocious puberty, medically necessary care for certain disorders of sex development, treatment of complications from prior procedures, and emergency care needed to prevent death or serious bodily harm. It also clarifies that the prohibition does not apply to mental or behavioral health services for minors related to gender dysphoria that do not involve the specified procedures or drugs.
Impact
The bill would amend section 340E of the Public Health Service Act, extending the children’s hospital graduate medical education payment program from 2023 to 2030 and revising the statutory funding authorizations for the program. It would also impose a new federal eligibility condition on participating children’s hospitals, affecting which hospitals may receive these payments beginning in fiscal year 2026. The measure would therefore affect children’s hospitals, pediatric training programs, and federal payment administration under the Public Health Service Act.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the measure appears to be framed as a support-and-reauthorization bill for children’s hospitals, but with a significant policy restriction attached. The sponsorship pattern suggests support from the bill’s House backers, while the added limitation on certain pediatric gender-related procedures indicates the bill is also intended to advance a specific social-policy position. No formal vote history is provided, so broader legislative sentiment cannot be measured from the record here.
Contention
The main point of contention is the new prohibition tying federal children’s hospital GME payments to whether a hospital provided specified gender-affirming procedures or medications to minors. Supporters are likely to view this as a safeguard on federal funds and a restriction on pediatric gender-transition care, while opponents would likely argue that it penalizes hospitals for providing medically appropriate care and interferes with physician judgment and patient access. The exceptions for precocious puberty, disorders of sex development, complications from prior treatment, and emergency care suggest an attempt to narrow the restriction, but the scope of the definition of “specified procedures and drugs” remains the central dispute.
To amend title III of the Public Health Service Act to reauthorize the program of payments to childrens hospitals that operate graduate medical education programs.